Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Would you consider adding adjuvant vaginal cuff brachytherapy for a FIGO 1A endometrial cancer, G1, no LVSI, based on the presence of extensive lower uterine segment involvement?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It’s not an absolute indication for adjuvant brachy with small absolute benefit.

Do you account for dose from previous Lu-177 treatment for definitive prostate cancer treatment?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Virginia Commonwealth University Medical Center

The short answer is yes. You'll have to assume that the entire bladder epithelium received that dose. However, due to dose rate effects, the equivalent dose to what would be delivered using external beam radiation will be less than 12.8 Gy. You should try to estimate an EQD2 for the Lutathera treatm...

In a patient s/p lumpectomy+RT for an early stage breast cancer, who later has recurrent disease requiring mastectomy and PMRT, under what circumstances would you recommend a boost?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

If already had WBI and now requiring PMRT, I only boost for positive margins, inflammatory recurrence, or if skin involvement.

What would be your approach for a patient with triple negative metastatic breast cancer with oligo-progressive disease in the axilla alone?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

Would evaluate with breast surgeon. Can consider surgery if other disease stable for > 6-12 mo, followed by +/- RT. Important to consider if primary was already treated and if this is on ipsilateral/contralateral side.

How would you proceed when a cervical cancer undergoing brachytherapy has exceeded the rectal dose but not met the target dose?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Rectal dose and target dose have range. Preferred rectal dose for D2cc < 65 Gy but can accept up to D2cc < 75 Gy, provided you understand expected risk of complications with increased dose. Preference would be to do hybrid applicator with 3D imaging to optimize HRCTV and OAR.

How would you approach a resected solitary osseous plasmacytoma?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

With a few exceptions, surgery is rarely pursued as a definitive modality in hematologic malignancies. I have never seen an orthopedic oncologist attempt an oncologic resection for a solitary plasmacytoma of bone, so my subsequent thoughts are theoretical. In the (very unusual) situation posed, if t...

How would you manage a dehiscent vaginal cuff 2 months after vaginal cuff brachytherapy?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It has to be a combination of surgery and radiation. Partial small dehiscence can sometimes be managed conservatively otherwise, most need surgical fixation.

In a patient with favorable risk pT1N0(mic/i+) breast cancer and favorable anatomy, would you use IMPORT-LOW style PBI while incorporating the high axilla?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

For N0(i+), PBI is appropriate, I would not include axilla. 40/15, 30/5. If N1mic, would not use PBI but would favor WBI, high tangents if ER+, RNI if ER-.

Would you use IMRT to treat stage II seminoma?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Karmanos Cancer Institute - McLaren Proton Therapy Center

I wouldn't use IMRT, but I have used protons in 20-40 year old patients, who, like peds, have a long lifetime at risk of secondary malignancy. The NCCN guidelines for Seminoma, Principles of Radiation Therapy, specifically advise against using IMRT and recommend 3D conformal. This is due to fear of ...

How would you treat a recurrent ovarian malignant mixed Mullerian tumor on the pelvic side wall?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would treat with IMRT and IGRT with total dose equivalent to 66 Gy based on OAR dosimetry to buy time without chemo and improve PFS.